GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » Beneish M-Score

Pilulka Lekarny AS (XPRA:PINK) Beneish M-Score : -3.95 (As of Jun. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.95 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Pilulka Lekarny AS's Beneish M-Score or its related term are showing as below:

XPRA:PINK' s Beneish M-Score Range Over the Past 10 Years
Min: -3.95   Med: -2.95   Max: 52.83
Current: -3.95

During the past 6 years, the highest Beneish M-Score of Pilulka Lekarny AS was 52.83. The lowest was -3.95. And the median was -2.95.


Pilulka Lekarny AS Beneish M-Score Historical Data

The historical data trend for Pilulka Lekarny AS's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pilulka Lekarny AS Beneish M-Score Chart

Pilulka Lekarny AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -3.12 -2.77 52.83 -3.95

Pilulka Lekarny AS Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score Get a 7-Day Free Trial - -3.12 -2.77 52.83 -3.95

Competitive Comparison of Pilulka Lekarny AS's Beneish M-Score

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's Beneish M-Score falls into.



Pilulka Lekarny AS Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Pilulka Lekarny AS for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.013+0.528 * 1.3371+0.404 * 1.1136+0.892 * 0.8711+0.115 * 0.7218
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.319884-0.327 * 1.2021
=-3.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was Kč167 Mil.
Revenue was Kč2,132 Mil.
Gross Profit was Kč169 Mil.
Total Current Assets was Kč279 Mil.
Total Assets was Kč440 Mil.
Property, Plant and Equipment(Net PPE) was Kč58 Mil.
Depreciation, Depletion and Amortization(DDA) was Kč74 Mil.
Selling, General, & Admin. Expense(SGA) was Kč0 Mil.
Total Current Liabilities was Kč396 Mil.
Long-Term Debt & Capital Lease Obligation was Kč4 Mil.
Net Income was Kč-175 Mil.
Gross Profit was Kč0 Mil.
Cash Flow from Operations was Kč-34 Mil.
Total Receivables was Kč189 Mil.
Revenue was Kč2,447 Mil.
Gross Profit was Kč260 Mil.
Total Current Assets was Kč404 Mil.
Total Assets was Kč606 Mil.
Property, Plant and Equipment(Net PPE) was Kč74 Mil.
Depreciation, Depletion and Amortization(DDA) was Kč51 Mil.
Selling, General, & Admin. Expense(SGA) was Kč0 Mil.
Total Current Liabilities was Kč434 Mil.
Long-Term Debt & Capital Lease Obligation was Kč25 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(166.568 / 2131.849) / (188.752 / 2447.297)
=0.078133 / 0.077127
=1.013

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(259.595 / 2447.297) / (169.121 / 2131.849)
=0.106074 / 0.079331
=1.3371

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (279.099 + 57.627) / 439.7) / (1 - (404.176 + 74.354) / 605.963)
=0.234191 / 0.210298
=1.1136

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2131.849 / 2447.297
=0.8711

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(50.822 / (50.822 + 74.354)) / (74.087 / (74.087 + 57.627))
=0.406004 / 0.562484
=0.7218

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 2131.849) / (0 / 2447.297)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.675 + 396.223) / 439.7) / ((24.8 + 433.642) / 605.963)
=0.909479 / 0.756551
=1.2021

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-174.943 - 0 - -34.29) / 439.7
=-0.319884

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Pilulka Lekarny AS has a M-score of -3.95 suggests that the company is unlikely to be a manipulator.


Pilulka Lekarny AS Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Pilulka Lekarny AS (XPRA:PINK) Business Description

Traded in Other Exchanges
N/A
Address
Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS (XPRA:PINK) Headlines

From GuruFocus

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-31-2022

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor 02-02-2023